411 related articles for article (PubMed ID: 20081135)
1. Clinical presentation, treatment, and complications of malignant hyperthermia in North America from 1987 to 2006.
Larach MG; Gronert GA; Allen GC; Brandom BW; Lehman EB
Anesth Analg; 2010 Feb; 110(2):498-507. PubMed ID: 20081135
[TBL] [Abstract][Full Text] [Related]
2. Cardiac arrests and deaths associated with malignant hyperthermia in north america from 1987 to 2006: a report from the north american malignant hyperthermia registry of the malignant hyperthermia association of the United States.
Larach MG; Brandom BW; Allen GC; Gronert GA; Lehman EB
Anesthesiology; 2008 Apr; 108(4):603-11. PubMed ID: 18362591
[TBL] [Abstract][Full Text] [Related]
3. Malignant hyperthermia deaths related to inadequate temperature monitoring, 2007-2012: a report from the North American malignant hyperthermia registry of the malignant hyperthermia association of the United States.
Larach MG; Brandom BW; Allen GC; Gronert GA; Lehman EB
Anesth Analg; 2014 Dec; 119(6):1359-66. PubMed ID: 25268394
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the clinical variables associated with recrudescence after malignant hyperthermia reactions.
Burkman JM; Posner KL; Domino KB
Anesthesiology; 2007 May; 106(5):901-6; quiz 1077-8. PubMed ID: 17457120
[TBL] [Abstract][Full Text] [Related]
5. Complications associated with the administration of dantrolene 1987 to 2006: a report from the North American Malignant Hyperthermia Registry of the Malignant Hyperthermia Association of the United States.
Brandom BW; Larach MG; Chen MS; Young MC
Anesth Analg; 2011 May; 112(5):1115-23. PubMed ID: 21372281
[TBL] [Abstract][Full Text] [Related]
6. Hyperthermia in the pediatric intensive care unit--is it malignant hyperthermia?
Schleelein LE; Litman RS
Paediatr Anaesth; 2009 Nov; 19(11):1113-8. PubMed ID: 19694974
[TBL] [Abstract][Full Text] [Related]
7. The severity of sevoflurane-induced malignant hyperthermia.
Migita T; Mukaida K; Kobayashi M; Hamada H; Kawamoto M
Acta Anaesthesiol Scand; 2012 Mar; 56(3):351-6. PubMed ID: 22092278
[TBL] [Abstract][Full Text] [Related]
8. Malignant hyperthermia in Canada: characteristics of index anesthetics in 129 malignant hyperthermia susceptible probands.
Riazi S; Larach MG; Hu C; Wijeysundera D; Massey C; Kraeva N
Anesth Analg; 2014 Feb; 118(2):381-387. PubMed ID: 23842196
[TBL] [Abstract][Full Text] [Related]
9. Postoperative malignant hyperthermia: an analysis of cases from the North American Malignant Hyperthermia Registry.
Litman RS; Flood CD; Kaplan RF; Kim YL; Tobin JR
Anesthesiology; 2008 Nov; 109(5):825-9. PubMed ID: 18946294
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of malignant hyperthermia episodes with the Clinical Grading Scale].
von Richthofen V; Wappler F; Scholz J; Fiege M; Schulte am Esch J
Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Apr; 33(4):244-9. PubMed ID: 9617423
[TBL] [Abstract][Full Text] [Related]
11. Malignant hyperthermia: current perspectives.
Felice-Johnson J; Sudds T; Bennett G
Am J Hosp Pharm; 1981 May; 38(5):646-51. PubMed ID: 7282692
[TBL] [Abstract][Full Text] [Related]
12. [Malignant hyperthermia in a child with acute lymphatic leukemia].
Sailer R; Hinrichs B; Mantel K
Anaesthesist; 1991 May; 40(5):298-301. PubMed ID: 1867372
[TBL] [Abstract][Full Text] [Related]
13. Malignant hyperthermia in the otology patient: the UCLA experience.
Wackym PA; Blackwell KE
Am J Otol; 1994 May; 15(3):371-5. PubMed ID: 8579142
[TBL] [Abstract][Full Text] [Related]
14. Postoperative malignant hyperthermia confirmed by calcium-induced calcium release rate after breast cancer surgery, in which prompt recognition and immediate dantrolene administration were life-saving: a case report.
Miyazaki N; Kobayashi T; Komiya T; Okada T; Ishida Y; Fukui H; Ogihara Y; Uchino H
J Med Case Rep; 2021 Apr; 15(1):201. PubMed ID: 33863374
[TBL] [Abstract][Full Text] [Related]
15. [Malignant hyperthermia].
Schulte-Sasse U; Eberlein HJ
Anaesthesist; 1983 Apr; 32(4):141-57. PubMed ID: 6349413
[TBL] [Abstract][Full Text] [Related]
16. [Intraoperative malignant hyperthermia: apropos of a case].
Madi-Jebara S; Yazbeck P; Bou-Khalil M; Cherfane A; Antakly MC
J Med Liban; 1997; 45(1):36-9. PubMed ID: 9453994
[TBL] [Abstract][Full Text] [Related]
17. Clinical features and diagnosis for Chinese cases with malignant hyperthermia: a case cluster from 2005 to 2007.
Wang YL; Luo AL; Tan G; Cui XL; Guo XY
Chin Med J (Engl); 2010 May; 123(10):1241-5. PubMed ID: 20529573
[TBL] [Abstract][Full Text] [Related]
18. Anesthetic drugs and onset of malignant hyperthermia.
Visoiu M; Young MC; Wieland K; Brandom BW
Anesth Analg; 2014 Feb; 118(2):388-396. PubMed ID: 24445637
[TBL] [Abstract][Full Text] [Related]
19. Malignant hyperthermia: a potentially fatal complication of anesthesia.
Stolworthy C; Haas RE
Semin Perioper Nurs; 1998 Jan; 7(1):58-66. PubMed ID: 9510843
[TBL] [Abstract][Full Text] [Related]
20. Succinylcholine Use and Dantrolene Availability for Malignant Hyperthermia Treatment: Database Analyses and Systematic Review.
Larach MG; Klumpner TT; Brandom BW; Vaughn MT; Belani KG; Herlich A; Kim TW; Limoncelli J; Riazi S; Sivak EL; Capacchione J; Mashman D; Kheterpal S; Kooij F; Wilczak J; Soto R; Berris J; Price Z; Lins S; Coles P; Harris JM; Cummings KC; Berman MF; Nanamori M; Adelman BT; Wedeven C; LaGorio J; McCormick PJ; Tom S; Aziz MF; Coffman T; Ellis TA; Molina S; Peterson W; Mackey SC; van Klei WA; Ginde AA; Biggs DA; Neuman MD; Craft RM; Pace NL; Paganelli WC; Durieux ME; Nair BJ; Wanderer JP; Miller SA; Helsten DL; Turnbull ZA; Schonberger RB;
Anesthesiology; 2019 Jan; 130(1):41-54. PubMed ID: 30550426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
